Department of Medicine Columbia University Medical Center New York NY.
Department of Medicine Hospital of the University of Pennsylvania Philadelphia PA.
J Am Heart Assoc. 2020 Oct 20;9(19):e017430. doi: 10.1161/JAHA.120.017430. Epub 2020 Sep 14.
Background Right bundle-branch block (RBBB) occurs in 0.2% to 1.3% of people and is considered a benign finding. However, some studies have suggested increased risk of cardiovascular morbidity and mortality. We sought to evaluate risk attributable to incidental RBBB in patients without prior diagnosis of cardiovascular disease (CVD). Methods and Results We reviewed the Mayo Clinic Integrated Stress Center database for exercise stress tests performed from 1993 to 2010. Patients with no known CVD-defined as absence of coronary disease, structural heart disease, heart failure, or cerebrovascular disease-were selected. Only Minnesota residents were included, all of whom had full mortality and outcomes data. There were 22 806 patients without CVD identified; 220 of whom (0.96%) had RBBB, followed for 6 to 23 years (mean 12.4±5.1). There were 8256 women (36.2%), mean age was 52±11 years; and 1837 deaths (8.05%), including 645 cardiovascular-related deaths (2.83%), occurred over follow-up. RBBB was predictive of all-cause (hazard ratio [HR], 1.5; 95% CI, 1.1-2.0; =0.0058) and cardiovascular-related mortality (HR,1.7; 95% CI, 1.1-2.8; =0.0178) after adjusting for age, sex, diabetes mellitus, hypertension, obesity, current and past history of smoking, and use of a heart rate-lowering drug. Patients with RBBB exhibited more hypertension (34.1% versus 23.7%, <0.0003), decreased functional aerobic capacity (82±25% versus 90±24%; <0.0001), slower heart rate recovery (13.5±11.5 versus 17.1±9.4 bpm; <0.0001), and more dyspnea (28.2% versus 22.4%; <0.0399) on exercise testing. Conclusions Patients with RBBB without CVD have increased risk of all-cause mortality, cardiovascular-related mortality, and lower exercise tolerance. These data suggest RBBB may be a marker of early CVD and merit further prospective evaluation.
右束支传导阻滞(RBBB)在 0.2%至 1.3%的人群中发生,被认为是良性发现。然而,一些研究表明其心血管发病率和死亡率风险增加。我们旨在评估在无心血管疾病(CVD)既往诊断的患者中,偶然发生的 RBBB 的归因风险。
我们回顾了 1993 年至 2010 年期间在梅奥诊所综合应激中心进行的运动压力测试的数据库。选择了无已知 CVD 的患者(定义为无冠状动脉疾病、结构性心脏病、心力衰竭或脑血管疾病)。仅纳入明尼苏达州居民,所有患者均有完整的死亡率和结局数据。共确定了 22806 例无 CVD 的患者;其中 220 例(0.96%)存在 RBBB,随访时间为 6 至 23 年(平均 12.4±5.1 年)。患者中 8256 例为女性(36.2%),平均年龄为 52±11 岁;随访期间共发生 1837 例死亡(8.05%),其中 645 例为心血管相关死亡(2.83%)。RBBB 与全因死亡率(危险比 [HR],1.5;95%置信区间,1.1-2.0;=0.0058)和心血管相关死亡率(HR,1.7;95%置信区间,1.1-2.8;=0.0178)相关,校正年龄、性别、糖尿病、高血压、肥胖、目前和既往吸烟史以及使用心率降低药物后。与无 RBBB 的患者相比,存在 RBBB 的患者有更多的高血压(34.1%比 23.7%,<0.0003)、较低的功能有氧能力(82±25%比 90±24%;<0.0001)、较慢的心率恢复(13.5±11.5 比 17.1±9.4 bpm;<0.0001)和更多的呼吸困难(28.2%比 22.4%;<0.0399)。
无 CVD 的 RBBB 患者全因死亡率、心血管相关死亡率风险增加,运动耐量降低。这些数据表明 RBBB 可能是早期 CVD 的标志物,值得进一步前瞻性评估。